ABCA12 Is a Major Causative Gene for Non-Bullous Congenital Ichthyosiform Erythroderma  by Sakai, Kaori et al.
Tasanen K, Floeth M, Schumann H, Bruckner-
Tuderman L (2000) Hemizygosity for a
glycine substitution in collagen XVII: unfold-
ing and degradation of the ectodomain.
J Invest Dermatol 115:207–12
Tromp G, Kuivaniemi H, Stolle C, Pope FM,
Prockop DJ (1989) Single base mutation in
the type III procollagen gene that converts the
codon for glycine 883 to aspartate in a mild
variant of Ehlers-Danlos syndrome IV. J Biol
Chem 264:19313–7
Va¨isa¨nen L, Has C, Franzke C, Hurskainen T,
Tuomi ML, Bruckner-Tuderman L et al.
(2005) Molecular mechanisms of junctional
epidermolysis bullosa: Col15 domain muta-
tions decrease the thermal stability of col-
lagen XVII. J Invest Dermatol 125:1112–8
Varki R, Sadowski S, Pfender E, Uitto J (2006)
Epidermolysis bullosa. Molecular genetics of
the junctional and hemidesmosomal variants.
J Med Genet 43:641–52
Westerhausen A, Kishi J, Prockop DJ (1990)
Mutations that substitute serine for glycine
a1-598 and glycine a1-631 in type I procol-
lagen. J Biol Chem 265:13995–4000
ABCA12 Is a Major Causative Gene for Non-Bullous
Congenital Ichthyosiform Erythroderma
Journal of Investigative Dermatology (2009) 129, 2306–2309; doi:10.1038/jid.2009.23; published online 5 March 2009
TO THE EDITOR
Non-bullous congenital ichthyosiform
erythroderma (NBCIE) and lamellar
ichthyosis (LI) are both heterogeneous
genetic disorders, and several causative
molecules, including ABCA12 and
transglutaminase-1 (TGase1), have
been identified (Huber et al., 1995;
Russell et al., 1995; Jobard et al., 2002;
Lefe´vre et al., 2003; Akiyama, 2006;
Lefe`vre et al., 2004, 2006). Patients
with NBCIE exhibit fine, whitish scales
on a background of erythematous
skin over the whole body. Conversely,
LI is clinically characterized by large,
thick, and dark scales over the entire
body without serious background
erythroderma.
ABCA12 missense mutations leading
to defects in the adenosine tripho-
sphate-binding cassette were reported
in LI cases (Lefe´vre et al., 2003), and
ABCA12 truncation mutations were
reported in patients with harlequin
ichthyosis (Akiyama et al., 2005; Kelsell
et al., 2005). Recently, we also identi-
fied ABCA12 missense mutations in a
small number of NBCIE cases (Natsuga
et al., 2007; Akiyama et al., 2008).
Since the first identification of
TGase1 gene (TGM1) mutations in LI
(Huber et al., 1995; Russell et al.,
1995), more than 50 TGM1 mutations
have been reported in LI. In addition,
TGM1 mutations were reported in a
subset of patients with NBCIE (Laiho
et al., 1997; Akiyama et al., 2001a;
Becker et al., 2003).
A number of reports concluded that
there was no clear correlation between
clinical differentiation of NBCIE and LI
and the genetic heterogeneity under-
lying these autosomal recessive conge-
nital ichthyoses (Hennies et al., 1998;
Richard, 2004). The clinical subgroups
of NBCIE and LI were not always
carefully and consistently recorded in
publications, and a number of genetic
studies were conducted including both
NBCIE and LI patients as autosomal
recessive congenital ichthyosis cases,
without detailed clinical information
for the patients. Thus, uncertainty has
often surrounded reports of NBCIE and
LI patients for whom there have been
accounts of published mutations, as
well as their references to previous
publications.
To assess the frequency of ABCA12
and TGM1 mutations in Japanese
NBCIE and LI families, we performed
mutational analyses in eight NBCIE
families and nine LI families as a cohort
of Japanese autosomal recessive con-
genital ichthyosis patients.
The eight unrelated NBCIE families
and nine independent LI families were
seen at Hokkaido University Hospital
or were seen by other clinicians within
Japan. All the patients included in the
study showed a typical phenotype of
either NBCIE or LI. Only one patient,
LI1, had an apparent history as a
collodion baby at birth. Fully informed
consent was obtained from the partici-
pants or their legal guardians. The study
had been evaluated and approved by
the Ethical Committee at Hokkaido
University Graduate School of Medi-
cine and was conducted according to
the Declaration of Helsinki Principles.
TGM1 and ABCA12 mutations have
been considered major causative fac-
tors of autosomal recessive congenital
ichthyosis in Japanese patients (Akiya-
ma et al., 2003, 2008), but several other
causative molecules are also known
(Akiyama and Shimizu, 2008). There-
fore, the entire coding regions of
ABCA12 and TGM1, including the
exon/intron boundaries, were se-
quenced using genomic DNA samples
from patients and their family members.
One hundred normal alleles from un-
related, healthy Japanese individuals
were sequenced as normal controls.
Among eight independent NBCIE
families (one patient in each family)
(Table 1), ABCA12 mutations were
detected in five independent NBCIE
families (one patient in each family),
even though direct sequence analysis
revealed no TGM1 mutation in the
NBCIE families. A total of six ABCA12
mutations were identified, and four of
them—p.Trp1235Ser in the extracellu-
lar domain between the fifth and
the sixth transmembrane domains,
p.Pro1798Leu in the extracellular do-
main close to the seventh transmem-
brane domain, p.Thr1980Lys in the
Abbreviations: LI, lamellar ichthyosis; NBCIE, non-bullous congenital ichthyosiform erythroderma; SNP,
single-nucleotide polymorphism; TGase1, transglutaminase-1
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extracellular domain close to the
eighth transmembrane domain, and
p.Arg2482X in the second adenosine
triphosphate-binding cassette—were
previously unidentified mutations. All
the ABCA12 mutations in NBCIE were
missense mutations, and ABCA12 trun-
cation mutations were not found in any
of the NBCIE families.
We identified TGM1 mutations in
seven of the nine Japanese LI families in
this study (Table 1). Seven mutations were
identified: c.919C4T (p.Arg307Trp) in
three families, p.Arg155Trp in two fa-
milies, and p.Arg143Cys, p.Arg286Gln,
p.Arg291Ser, c.845_849delinsTAA, and
p.Asn125Thr in one family each. Three of
these mutations—c.842_846delinsTTA
and p.Gly291Ser in the catalytic
core domain and p.Arg155trp in the
b-sandwich domain—were previously
unidentified.
In the present study, only one of
the presumed two mutant alleles was
detected in NBCIE and LI patients (in
five of the 12 probands). NBCIE and LI
are autosomal recessive diseases, and
we assume that the other unidentified
mutations in these patients are hetero-
zygous exon-deletion mutations or
mutations in the promoter regions
or within introns, which cannot be
detected by conventional sequencing
of the coding regions. In fact, hetero-
zygous exon-deletion mutations of
ABCA12, which were not detected by
direct sequencing, were reported in
harlequin ichthyosis patients (Thomas
et al., 2006). To confirm this hypoth-
esis, immunofluorescence studies for
ABCA12 and glucosylceramide were
performed as described earlier (Akiya-
ma et al., 2006) in skin samples from
two NBCIE patients, NBCIE1 and
NBCIE2, both with a single identified
ABCA12 mutated allele. The results
demonstrated an intense ABCA12 stain-
ing within the granular layer cells of
normal epidermis that was absent in the
epidermis of both patients (Figure S1).
Immunofluorescent staining showed
that glucosylceramide was sparsely
distributed in the upper layers of NBCIE
patients’ epidermis, compared with a
more restricted, but intense, distribution
in the granular layers of normal skin
(Figure S1). If the ABCA12 transporter
activity had been completely deficient
in the epidermis, the patients would
have shown a harlequin ichthyosis
phenotype, but they had an NBCIE
phenotype. The immunofluorescence
stainings were not sufficiently quantita-
tive, and, on the basis of the present
results, we cannot exclude the possibi-
lity that ABCA12 activity remained in
the patients’ epidermis. An in situ
TGase activity assay was performed
using monodansylcadaverine as a sub-
strate as previously described (Akiyama
et al., 2001b) in skin samples from two
LI patients: LI1, harboring two identi-
fied TGM1 mutations, and LI5, with
only one identified TGM1 mutation.
Under pH 7.4-buffered conditions, the
detection of TGase 1 activity (Raghu-
nath et al., 1998) demonstrated remark-
ably reduced membrane-associated
labeling in both patients’ epidermis
compared with that in control epider-
mis (Figure S2). These results confirmed
that defects in either ABCA12 or
TGase1 underlie NBCIE1, NBCIE2,
and LI5 diseases, in which ABCA12 or
Table 1. ABCA12 or TGM1 mutations in NBCIE and LI patients included in
this study and our previous reports
Patient
no. Age Sex ABCA12 mutation TGM1 mutation References
NBCIE1 0 F p.[Pro1798Leu]+[?] () This study
NBCIE2 1 F p.[Thr1980Lys]+[?] () This study
NBCIE3 2 M () () This study
NBCIE4 2 F () () This study
NBCIE5 6 M p.[Arg1950X]+
[Trp1235Ser]
() This study
NBCIE6 9 F () () This study
NBCIE7 11 F p.[Arg2482X]+[?] () This study
NBCIE8 52 M p.[Arg1514His]+[=] () This study
NBCIE9 0 M () p.[Arg389His]+c.[2111delA] Akiyama
et al. (2001a)
NBCIE10 37 F p.[Thr345Pro]+[=] () Natsuga et al.
(2007)
NBCIE11 42 M p.[Ile1494Thr]+[?] () Natsuga et al.
(2007)




LI1 0 M () p.[Arg307Trp]+[=] This study
LI2 0 F () p.[Arg307Trp]+
c.[842_846delCACAGinsTAA]
This study
LI3 0 M () p.[Arg143Cys]+[Arg307Trp] This study
LI4 0 F () p.[Arg286Gln]+[Gly291Ser] This study
LI5 0 F () p.[Arg155Trp]+[?] This study
LI6 6 F () () This study
LI7 20 F () p.[Asn125Thr]+[=] This study
LI8 21 F () p.[Arg155Trp]+[?] This study
LI9 72 F () () This study
LI10 56 F () p.[Leu205Gln]+[Arg307Trp] Akiyama
et al. (2001b)
LI11 33 F () c.[371delA]+[=] Akiyama
et al. (2003)
LI, lamellar ichthyosis; NBCIE, non-bullous congenital ichthyosiform erythroderma.
() No mutation detected. Previously unidentified mutations are underlined.
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TGM1 mutations were identified in
only one allele.
In addition to the NBCIE and LI cases
reported here, we reviewed previously
performed mutational research on four
NBCIE cases (Akiyama et al., 2001a,
2008; Natsuga et al., 2007) and two LI
cases (Akiyama et al., 2001b, 2003)
(Table 1). Therefore, the total number of
Japanese NBCIE and LI families we
examined were 12 NBCIE and 11 LI
families. These diseases are extremely
rare; their frequency in the Japanese
population is 1 in 300,000–500,000
live births, and the number of live
births in Japan per year is approxi-
mately 1,090,000 (1,089,745 in 2007).
It is thus estimated that only two or
three individuals with NBCIE or LI are
born each year in Japan. In this context,
the 23 families in our cohort can be
expected to represent most of the new-
born patients for a decade in Japan and
therefore to be a significant sample of
the Japanese NBCIE and LI populations.
Interestingly, ABCA12 mutations were
frequently seen in Japanese NBCIE pa-
tients but were not detected in any of the
11 LI families. Thus, ABCA12 appears to
be a more important gene underlying
NBCIE than was previously thought, at
least in the Japanese population.
In our cohorts, TGM1 mutations
were detected in 9 of 11 LI families
and in only 1 of 12 NBCIE families. In
the literature to date, only seven NBCIE
TGM1 mutations have been reported in
unrelated families (Laiho et al., 1997;
Akiyama et al., 2001a; Becker et al.,
2003). From the present data, we
suggest that the frequency of TGM1
mutations as a primary cause of NBCIE
is relatively low, at least in the Japanese
population.
In the present study, the LI patient
mutation c.919C4T (p.Arg307Trp) was
found in three LI families out of seven
families with TGM1 mutations. In
addition, c.919C4T (p.Arg307Trp)
had previously been reported in three
Japanese LI families (Yang et al., 2001;
Akiyama et al., 2001b; Muramatsu
et al., 2004). Thus, we now know that
c.919C4T (p.Arg307Trp) is the first
common mutation to be found in the
Japanese LI patient population. Among
all the reported Japanese LI or NBCIE
families with TGM1 mutations, includ-
ing families in the present study (a total
of 14 families), the c.919C4T
(p.Arg307Trp) mutation was found in
six families. We screened more than
200 unrelated Japanese individuals as
controls, but failed to find the
p.Arg307Trp allele. Thus, although we
could not determine its exact allele
frequency, it is thought to be very low.
The TGM1 mutation p.Arg307Trp,
which is common in the Japanese
population, was identified in only one
Korean LI patient (Yang et al., 2001) in
all the studied populations outside
Japan; this might be a common LI
mutation only in the Japanese popula-
tion. To investigate whether a specific
haplotype was associated with the
p.Arg307Trp mutation, we analyzed
five single-nucleotide polymorphisms
(SNPs) within the TGM1 gene in the
four families harboring this mutation:
three families from the present study
and a previously reported family
(Akiyama et al., 2001b). In all four
families, p.Arg307Trp mutant alleles
had a C nucleotide at SNP rs2229463
(a T-to-C SNP; C-allele frequency¼
46.7%), a T nucleotide at SNP
rs2256989 (a C-to-T SNP; T-allele
frequency¼ 44.4%), a G nucleotide
at SNP rs8193033 (an A-to-G SNP;
G-allele frequency¼57.8%), a G
nucleotide at SNP rs8193032 (a T-to-G
SNP; G-allele frequency¼35.6%), and
a G nucleotide at SNP rs3814813 (a
C-to-G SNP; G-allele frequency¼
45.6%). We demonstrated that all the
TGM1 mutant alleles associated with
p.Arg307Trp shared the same five SNP
nucleotides, suggesting that the muta-
tion had a single origin. Thus, the high
frequency of the mutation is thought to
be due to a founder effect.
Summarizing the present results,
ABCA12 mutations were frequently
found in NBCIE families (in five of eight
families), but not in LI families. In
contrast, TGM1 mutations were fre-
quently detected in LI families (in seven
of nine families), but were rare in
NBCIE families. TGM1 mutations in
Japanese LI patients showed a founder
effect. In conclusion, the present results
suggest that ABCA12 and TGM1 are the
major causative genes in NBCIE and LI,
respectively, at least in the Japanese
population, although this situation
would clearly be different from that in
Europe. Thus, when we speculate about
candidate causative genes, it may be
useful to make a distinct diagnosis of LI
or NBCIE from the salient clinical
features in autosomal recessive conge-
nital ichthyosis patients in the Japanese
population.
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SUPPLEMENTARY MATERIAL
Figure S1. Double immunolabeling of ABCA12
and glucosylceramide in the epidermis.
Figure S2. Reduced in situ TGase 1 activity in the
patients’ epidermis.
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Proprotein Isoforms of Desmoglein 3
Journal of Investigative Dermatology (2009) 129, 2309–2312; doi:10.1038/jid.2009.41; published online 12 March 2009
TO THE EDITOR
The desmosomal cadherins desmoglein
(DSG) 3 and DSG1 are targets of
autoantibodies in the potentially fatal
blistering disease, pemphigus vulgaris
(PV) (Stanley and Amagai, 2006). DSGs
are synthesized as preproproteins,
which are processed first in the endo-
plasmic reticulum to remove the signal
sequence and subsequently by the
Golgi proprotein convertases to remove
the propeptide before transport to the
cell surface. The cadherin propeptide is
thought to modulate the conformation
of the extracellular domains to prevent
intracellular aggregation because of
interaction with other cadherins within
the secretory pathway. Propeptide clea-
vage occurs upstream of the conserved
tryptophan residue at position 2, which
is responsible for cadherin strand dimer
formation, suggesting that propeptide
removal may unmask residues impor-
tant in intermolecular adhesion. The
proprotein convertase furin processes
recombinant DSGs in baculoviral over-
expression systems (Posthaus et al.,
2003), which are widely used for
pemphigus research and clinical
diagnostic purposes. Commercial DSG
ELISA kits use baculovirally produced
recombinant DSG antigen (Ag) and
have been shown to be a sensitive and
specific diagnostic tool for pemphigus
(Ishii et al., 1997).Abbreviations: Ag, antigen; DSG3, desmoglein 3; PV, pemphigus vulgaris
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